In contrast, CCL18+ macrophages showed a dominant M2-like phenotype with the high expression of CD163, MARCO, and CSF1R, suggesting their stronger tumor-promoting role than SPP1+ macrophages (Supplementary Fig. 8d). The gene discussed is MARCO; the disease is neoplasm.